제 2형 당뇨병 환자의 유방암 발생 위험 및 사망률에 대한 메트포민의 영향: 체계적 문헌고찰 및 메타분석

키워드

참고문헌 (45)

1. American Diabetes Association., "Diagnosis and Classification of Diabetes Mellitus", Diabetes Care, 31(Suppl 1), pp.S55~S60 (2008)
2. Jemal A., "Global cancer statistics", CA Cancer J Clin, 61, pp.69~ (2011)
3. Moolgavkar SH., "Two-stage model for carcinogenesis : Epidemiology of breast cancer in females", J Natl Cancer Inst, 65, pp.559~569 (1980)
4. Colditz GA., "Cumulative risk of breast cancer to age 70 years according to risk factor status : data from the Nurses' Health Study", Am J Epidemiol, 152, pp.950~964 (2000)
5. Eliassen AH., "Adult weight change and risk of postmenopausal breast cancer", JAMA, 296, pp.193~201 (2006)
6. Boyd NF., "Mammographic density and the risk and detection of breast cancer", N Engl J Med, 356, pp.227~236 (2007)
7. Chen S., "Meta-analysis of BRCA1 and BRCA2 penetrance", J Clin Oncol, 25, pp.1329~1333 (2007)
8. Resta F., "The impact of body mass index and type 2 diabetes on breast cancer : current therapeutic measures of prevention", Curr Drug Targets Immune Endocr Metabol Disord, 4, pp.327~333 (2004)
9. Key TJ., "Epidemiology of breast cancer", Lancet Oncol, 2, pp.133~140 (2001)
10. Baron JA., "Metabolic disorders and breast cancer risk(United States)", Cancer Causes Control, 12, pp.875~880 (2001)
11. Lipscombe LL., "Increased prevalence of prior breast cancer in women with newly diagnosed diabetes", Breast Cancer Res Treat, 98, pp.303~309 (2006)
12. Arcidiacono B., "Insulin resistance and cancer risk : an overview of the pathogenetic mechanisms", Exp Diabetes Res, 2012, pp.789174~ (2012)
13. Zakikhani M., "Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells", Cancer Res, 66, pp.10269~10273 (2006)
14. Hundal RS., "Mechanism by which metformin reduces glucose production in type 2 diabetes", Diabetes, 49, pp.2063~2069 (2000)
15. Lee JH., "The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus", Int J Cancer, 131, pp.752~759 (2012)
16. Kourelis TV., "Metformin and cancer : new applications for an old drug", Med Oncol, 29, pp.1314~1327 (2012)
17. Bodmer M., "Use of metformin is not associated with a decreased risk of colorectal cancer : a case-control analysis", Cancer Epidemiol Biomarkers Prev, 21, pp.280~286 (2012)
18. Ladson G., "The effects of metformin with lifestyle therapy in polycystic ovary syndrome : a randomized doubleblind study", Fertil Steril, 95, pp.1059~1066 (2011)
19. "The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis"[URL]
20. Zheng JS., "Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies", BMJ, 346, pp.f3706~ (2013)
21. Libby G., "New users of metformin are at low risk of incident cancer : a cohort study among people with type 2 diabetes", Diabetes Care, 32, pp.1620~1625 (2009)
22. Bodmer M., "Long-term metformin use is associated with decreased risk of breast cancer", Diabetes Care, 33, pp.1304~1308 (2010)
23. Bosco JL., "Metformin and incident breast cancer among diabetic women : a population-based case-control study in Denmark", Cancer Epidemiol Biomarkers Prev, 20, pp.101~111 (2011)
24. Ruiter R., "Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives : results from a large population-based follow-up study", Diabetes Care, 35, pp.119~124 (2012)
25. Bayraktar S., "Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer", Cancer, 118, pp.1202~1211 (2012)
26. Hsieh MC., "The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese", Exp Diabetes Res, 2012, pp.413782~ (2012)
27. Qiu H., "Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus", Diabetes Obes Metab, 15, pp.349~357 (2013)
28. Redaniel MT., "Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality : a population-based cohort study among British women", Cancer Causes Control, 23, pp.1785~1795 (2012)
29. Tsilidis KK., "Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial", Diabetes Care, 37, pp.2522~2532 (2014)
30. Tseng CH, "Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes", Breast Cancer Res Treat, 145, pp.785~790 (2014)
31. Lega IC., "Association between metformin therapy and mortality after breast cancer : a population-based study", Diabetes Care, 36, pp.3018~3026 (2013)
32. Hou G., "Use of metformin and survival of diabetic women with breast cancer", Curr Drug Saf, 8, pp.357~363 (2013)
33. Green AS., "LKB1", AMPK, Cell Cycle, pp.2011, 10(13)[DOI]
34. Goodwin PJ., "Obesity and insulin resistance in breast cancer-- chemoprevention strategies with a focus on metformin", Breast, 20(Suppl 3), pp.S31~S35 (2011)
35. Col NF., "Metformin and breast cancer risk : a meta-analysis and critical literature review", Breast Cancer Res Treat, 135(3), pp.639~646 (2012)
36. Currie CJ., "The influence of glucose-lowering therapies on cancer risk in type 2 diabetes", Diabetologia, 52(9), pp.1766~1777 (2009)
37. Col NF., "Glucose lowering agents and the patterns of risk for cancer : a study with the General Practice Research Database and secondary care data", Diabetologia, 55(3), pp.654~665 (2012)
38. Staa Van., "Diabetes, metformin, and breast cancer in postmenopausal women", J Clin Oncol, 30, pp.2844~2852 (2012)
39. DeCensi A., "Metformin and cancer risk in diabetic patients : a systematic review and meta-analysis", Cancer Prev Res(Phila), 3(11), pp.1451~1461 (2010)
40. Stevens RJ., "Cancer outcomes and all-cause mortality in adults allocated to metformin : systematic review and collaborative meta-analysis of randomised clinical trials", Diabetologia, 55(10), pp.2593~2603 (2012)
41. Noto H., "Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis", PLoS One, 7(3), pp.e33411~ (2012)
42. Bowker SL., "Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin", Diabetes Care, 29(2), pp.254~258 (2006)
43. Landman GW., "Metformin associated with lower cancer mortality in type 2 diabetes : ZODIAC-16", Diabetes Care, 33(2), pp.322~326 (2010)
44. UK Prospective Diabetes Study(UKPDS)Group, "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes(UKPDS 34)", Lancet, 352(9131), pp.854~865 (1998)
45. Mellbin LG., "Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes : experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction(DIGAMI)2 Study", Diabetologia, 54(6), pp.1308~1317 (2011)

관련 논문AI추천